The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,065.00
Bid: 4,025.00
Ask: 4,040.00
Change: 35.00 (0.87%)
Spread: 15.00 (0.373%)
Open: 3,975.00
High: 4,065.00
Low: 3,970.00
Prev. Close: 4,030.00
RSW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

26 Oct 2023 07:00

RNS Number : 3073R
Renishaw PLC
26 October 2023
 

Renishaw plc

Trading update

26 October 2023

 

 

Steady recent performance in challenging market conditions

Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update for the three months ended 30 September 2023. It contains unaudited information that covers the first quarter of the financial year and the period since.

 

Trading activity

 

 

3 months to 30 September 2023

3 months to 30 September 2022

Change

 

 

 

 

Manufacturing technologies

£156.8m

£172.8m

-9%

Analytical instruments and medical devices

£7.7m

£7.1m

+8%

Total revenue

£164.5m

£179.9m

-9%

Total revenue at FY2023 exchange rates

£169.6m

£179.9m

-6%

 

 

 

Adjusted* profit before tax

£28.0m

£40.0m

-30%

Statutory profit before tax

£28.0m

£38.6m

-27%

 

Revenue was £164.5m, compared to £179.9m for the corresponding period last year, representing a 9% reduction and a 6% reduction at constant currency. All regions experienced reduced demand compared to Q1 FY2023. Whilst there was modest growth for the Industrial Metrology area of our business, revenues for our Position Measurement products were substantially below a strong period last year. However, compared to Q4 FY2023, revenue was 1% lower at constant currency, with no significant changes to market conditions.

 

In our Manufacturing technologies business, revenue amounted to £156.8m, compared to £172.8m last year. Revenue for our Analytical instruments and medical devices business was £7.7m, an increase of 8% compared with £7.1m last year.

 

Adjusted profit before tax for the first quarter amounted to £28.0m (FY2023: £40.0m) and was 4% lower than the final quarter of the previous financial year. Statutory profit before tax amounted to £28.0m (FY2023: £38.6m).

 

Financial position

The Group balance sheet remains strong with net cash and cash equivalents and bank deposit balances of £206.7m at 30 September 2023 (30 June 2023: £206.4m).

 

Outlook

Trading conditions remain challenging due to subdued demand, most notably from the semiconductor sector. We continue to see positive investment trends in robotics, defence, low emission transportation and additive manufacturing.

 

We continue to carefully manage costs, implement targeted price rises and focus on productivity improvements.

 

Our investments in product innovation, infrastructure, and people leave us well-positioned to benefit from a recovery in our markets. We are confident in our strategy to deliver sustainable long-term growth.

The results for the half year ending 31 December 2023 will be released on 6 February 2024.

 

Will Lee

Allen Roberts

 

Chief Executive

Group Finance Director

 

 

26 October 2023

 

 

Renishaw plc

Registered office

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number

01106260

Telephone number

+44 (0) 1453 524524

Website

www.renishaw.com

 

 

 

 

* The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS 9 'Financial Instruments'. The Board deems that the adjusted profit before tax also represents a useful measure of performance of the Group. All previously ineffective contracts matured in FY2023 and no further contracts have been designated as ineffective in FY2024. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

£'m

3 months to 30 September 2023

3 months to 30 September 2022

 

£'000

£'000

 

 

Statutory profit before tax

28.0

38.6

 

 

Fair value (gains)/losses on financial instruments not eligible for hedge accounting

 

- reported in revenue

-

(3.7)

- reported in (gains)/losses from the fair value of financial instruments

-

5.1

 

 

Adjusted profit before tax

28.0

40.0

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASESASKDFFA
Date   Source Headline
3rd Mar 20212:50 pmRNSForm 8.3 - Renishaw plc
3rd Mar 20212:47 pmRNSForm 8.3 - Renishaw plc
3rd Mar 20212:04 pmPRNForm 8.3 - Renishaw PLC
3rd Mar 20211:57 pmRNSForm 8.3 - Renishaw Plc
3rd Mar 20211:28 pmRNSForm 8.3 - [Renishaw Plc]
3rd Mar 202112:57 pmRNSForm 8.3 - Renishaw plc
3rd Mar 20219:58 amRNSForm 8.3 - Renishaw Plc
2nd Mar 20217:00 amRNSCommencement of Formal Sale Process
4th Feb 20217:00 amRNSHalf-year Report
28th Jan 20215:00 pmRNSNotice of Half-year Results
22nd Oct 20207:00 amRNSTrading Statement
5th Oct 20202:57 pmRNSDirector/PDMR Shareholding
30th Sep 20202:39 pmRNSResult of AGM
24th Sep 20207:00 amRNSDirectors' Remuneration Policy – Clarification
22nd Sep 20203:11 pmRNSReplacement Director/PDMR Shareholding
22nd Sep 20202:19 pmRNSDirector/PDMR Shareholding
8th Sep 20204:35 pmRNSDirector/PDMR Shareholding
1st Sep 20207:00 amRNSAnnual Financial Report
27th Aug 20207:00 amRNSDirector/PDMR Shareholding
17th Aug 20203:15 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSFinal Results
6th Aug 202010:00 amRNSNotice of Results
17th Jul 20208:06 amRNSTrading Statement
26th Jun 20201:08 pmRNSDirector/PDMR Shareholding
24th Jun 20203:35 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:17 pmRNSDirector/PDMR Shareholding
10th Jun 20202:00 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNS2020 Final Dividend
12th May 20207:00 amRNSTrading Statement
4th May 202012:00 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20204:30 pmRNSStatement re 2019 AGM resolution votes
25th Mar 20204:28 pmRNSStatement re Interim dividend
6th Mar 20209:36 amRNSDirector/PDMR Shareholding
27th Feb 20204:47 pmRNSStatement re Interim dividend
30th Jan 20207:00 amRNSHalf-year Report
29th Jan 20205:45 pmRNSChange in Director's Responsibilities
20th Jan 202012:00 pmRNSNotice of Half-year Results
17th Jan 20209:47 amRNSHolding(s) in Company
24th Oct 20193:37 pmRNSResult of AGM
15th Oct 20197:00 amRNSTrading Statement
30th Aug 20193:00 pmRNSPurchase of Shares by Profit Share Trust
21st Aug 20197:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSFinal Results
16th Jul 20193:00 pmRNSNotice of Results
25th Jun 20197:00 amRNSDirectorate Change
14th May 201910:00 amRNSDirector Declaration
14th May 20197:00 amRNSTrading Statement
27th Mar 201911:36 amRNSDirector/PDMR Shareholding
22nd Mar 20199:48 amRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.